Neuraptive Therapeutics, Inc.
New Filing
CIK: 0001713836·Biotechnology·PENNSYLVANIA·Filed: Oct 14, 2022
Total Offering
$38,132,939
Amount Sold
$19,490,348
Investors
71
First Sale
Sep 29, 2022
Offering Details
- Type
- Equity, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Robert S Radie | Related Person |
| Evan Tzanis | Related Person |
| Ivan Gergel | Related Person |
| David Jackson | Related Person |
| Greg Parekh | Related Person |
| David Pierce | Related Person |
| Randy Hubbell | Related Person |
Company
SEC Filing
0001878646-22-000047
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free